The impact of direct acting antivirals and inhibitors of host innate immune cell signalling (macrolide, SYK, PAD4) on innate immune cell function in response to infection of airway epithelial cells. (2017–2019)
- Grant type:
- Gilead Pty Ltd
- Researchers:
-
-
- Funded by:
- Gilead Sciences Pty Limited
